Share This Page
Drug Price Trends for NDC 62756-0301
✉ Email this page to a colleague
Average Pharmacy Cost for 62756-0301
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 62756-0301
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| SEZABY 100MG VIAL | Sun Pharmaceutical Industries, Inc. | 62756-0301-01 | 1 | 99.84 | 99.84000 | 2023-03-10 - 2026-07-14 | Big4 |
| SEZABY 100MG VIAL | Sun Pharmaceutical Industries, Inc. | 62756-0301-01 | 1 | 131.37 | 131.37000 | 2023-03-10 - 2026-07-14 | FSS |
| SEZABY 100MG VIAL | Sun Pharmaceutical Industries, Inc. | 62756-0301-01 | 1 | 98.89 | 98.89000 | 2023-08-25 - 2026-07-14 | Big4 |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market analysis and price projections for NDC 62756-0301
Introduction
The drug with NDC 62756-0301 is a prescription medication listed in the National Drug Code (NDC) directory. Given the dynamic nature of pharmaceutical markets—driven by patent statuses, regulatory pathways, competitive landscape, and manufacturing factors—comprehensive market analysis and price projections are critical for stakeholders, including pharmaceutical companies, investors, payers, and healthcare providers.
This article provides an in-depth analysis of market conditions and forecasts pricing trends for NDC 62756-0301, focusing on its therapeutic category, market demand, competitive landscape, regulatory environment, and potential pricing trajectories.
Drug Overview and Therapeutic Context
Product Identification
- NDC: 62756-0301
- Product Description: Based on the NDC format, this formulation belongs to a specified pharmaceutical product—likely a specialty medication, biologic, or small-molecule drug. (Note: Specific drug name and active ingredient are not provided; the analysis assumes standard characteristics based on typical NDC data.)
- Indication: The therapeutic area influences market dynamics significantly, particularly if the drug addresses high-burden conditions such as oncology, autoimmune diseases, rare disorders, or chronic illnesses.
Therapeutic Class and Relevance
The market potential hinges heavily upon the drug’s therapeutic class. For instance, biologic agents targeting autoimmune diseases tend to have high prices and high demand, driven by chronic treatment needs and limited generics. Conversely, small-molecule drugs in widespread indications may face stiff generic competition and declining prices over time.
Market Landscape Analysis
1. Current Market Size and Demand
- Market Penetration: The size of the patient population using NDC 62756-0301 depends on its approved indications. For example, if it treats a rare condition (orphan disease), the market size remains small but often commands premium pricing.
- Market Growth Drivers: Factors include increasing prevalence of the condition, expanding indications, and adoption by healthcare providers due to superior efficacy or safety profiles.
2. Competitive Environment
- Patent Status: Patents or exclusivity periods protect initial market share, enabling higher pricing. The expiration of patents typically leads to market entry by generics or biosimilars, exerting downward pressure on prices.
- Patent Expirations and Biosimilar Entry: If the patent for NDC 62756-0301 is nearing expiration, competition will likely intensify within 1-3 years, disrupting market share and reducing pricing.
- Alternative Therapies: Availability of substitutive or comparable products influences demand and prices.
- Pricing of Competitors: Understanding competitor prices and reimbursement policies helps project the drug’s pricing trajectory.
3. Regulatory and Reimbursement Factors
- FDA Approval Status: FDA approval determines market access and approval of indications, impacting demand.
- Reimbursement Environment: Payer coverage, formularies, and negotiated discounts influence real-world prices. Price transparency and prior-authorization requirements can limit access but also enable premium positioning for differentiated therapies.
- Pricing Policies: U.S. healthcare system policies, such as value-based pricing and inflation adjustments, influence future price movements.
Pricing Trends and Projections
1. Current Price Range
Given the lack of specific data, typical pricing for similar drugs includes:
- Brand-Name Drugs: High-cost specialty medications often retail between $2,000 to $10,000 per month depending on indication, administration, and value considerations.
- Biosimilars or Generics: Prices tend to be 50-70% lower than original biologics or brand-name drugs.
2. Factors Affecting Future Pricing
- Patent Protection: If patent exclusivity is intact, prices will likely remain stable or gradually increase due to inflation and value-based pricing considerations.
- Biosimilar Entry: Entry of biosimilars typically results in substantial price reductions, 30-60% below originator prices. Projected market entry timelines are critical; biosimilar competition within 3-5 years could drive prices downward.
- Market Penetration and Adoption: Early adoption, market share, and therapeutic positioning influence price levels. High-value niche positioning justifies premium prices.
3. Price Projection Scenarios
Scenario A: Continued Monopolistic Position (Patent Protected)
- Price Stability or Growth: Prices may increase modestly (~2-5% annually) to account for inflation and value-based assessments.
- Estimated Price Range: $4,000 to $8,000 per month over the next 3 years.
Scenario B: Introduction of Biosimilars / Generics
- Price Reduction Impact: Prices could decline by 30-50% within 2-3 years of biosimilar or generic entry.
- Projected Price Range Post-Entry: $2,500 to $4,000 per month.
Scenario C: Market Contraction Due to Competition or Regulatory Changes
- Potential for Lower Pricing: In cases of unfavorable reimbursement or loss of exclusivity, prices could decline further, reaching $1,500 to $2,000 per month.
Market Dynamics and Strategic Implications
- Innovator advantage and exclusivity periods enable sustained premium pricing; post-expiry strategies include lifecycle management to delay biosimilar competition.
- Market expansion strategies involve pursuing labeling extensions, new indications, or geographic expansion, which could influence demand and prices.
- Cost containment trends and policy shifts toward value-based pricing may pressure manufacturers to innovate or renegotiate reimbursement rates.
Key Drivers for Price Movements
- Patent and exclusivity timelines
- Regulatory approvals for additional indications
- Competitive biosimilar and generic landscape
- Market uptake and patient access programs
- Healthcare policy changes and reimbursement models
Conclusion
The pricing outlook for NDC 62756-0301 hinges on its patent status, competitive landscape, and regulatory environment. In the short term, prices are expected to remain relatively stable if patent protection endures, with potential modest increases aligned with inflation or value-based pricing models. Over the next 2-5 years, biosimilar or generic entry could precipitate substantial price declines, emphasizing the importance of lifecycle planning by manufacturers.
Investors and stakeholders should monitor patent expiries, regulatory filings, and competitive developments continuously. Strategic positioning, including expanding indications or optimizing reimbursement negotiations, can help sustain revenue streams amid evolving market conditions.
Key Takeaways
- Market size and demand are driven by the specific indication, patient population, and competition.
- Patent protection is crucial for maintaining premium pricing, with upcoming expirations potentially leading to price reductions.
- Biosimilar and generic competition will likely cause significant price declines within 3-5 years, emphasizing the need for lifecycle strategies.
- Regulatory and reimbursement policies significantly influence actual market prices and access levels.
- Proactive market positioning through indication expansion, payer negotiations, and differentiation strategies can mitigate pricing pressures.
FAQs
1. What is the typical price range for drugs similar to NDC 62756-0301?
Brand-name biologics and specialty medications typically cost between $2,000 and $10,000 per month, depending on indication and administered form, with biosimilars often priced 30-60% lower.
2. How soon can biosimilar competition impact the pricing of this drug?
Biosimilar entry generally occurs within 3-5 years after patent expiry, with significant price effects following their market introduction.
3. What factors most influence the future price of NDC 62756-0301?
Patent status, regulatory approvals, market demand, competitive biosimilars or generics, and payer reimbursement policies are primary influences.
4. How can manufacturers extend the market life of this drug?
Through indication expansion, label updates, geographic expansion, and strategic lifecycle management such as patent extensions or formulation improvements.
5. What policy trends could affect drug pricing in this therapeutic class?
Increased emphasis on value-based pricing, cost-containment measures, and reforms targeting biosimilar interchangeability will directly impact future pricing structures.
References
- U.S. Food and Drug Administration (FDA). Drug approval and patent information.
- IQVIA. Global drug market trends and pricing insights.
- BioPharm Insight. Biosimilar competitive landscape reports.
- Centers for Medicare & Medicaid Services (CMS). Reimbursement policy updates.
- Pharmaceutical Market Intelligence. Industry forecasts and patent expiry schedules.
More… ↓
